Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

---
identifier: "/us/fr/E9-24934"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
title_number: 0
title_name: "Federal Register"
section_number: "E9-24934"
section_name: "Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
positive_law: false
currency: "2009-10-16"
last_updated: "2009-10-16"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-24934"
document_type: "notice"
publication_date: "2009-10-16"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 53279"
fr_volume: 74
---


#  Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), CDC and HRSA announce the following meeting of the aforementioned committee:

*Times and Dates:*

8 a.m.-5:30 p.m., November 2, 2009.

8 a.m.-3 p.m., November 3, 2009.

*Place:* Hyatt Regency Bethesda, 7400 Wisconsin Avenue (One Bethesda Metro Center), Bethesda, Maryland 20814, Telephone: (301) 657-1234.

*Status:* Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

*Purpose:* This Committee is charged with advising the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs, the support of health care services to persons living with HIV/AIDS, and education of health professionals and the public about HIV/AIDS and other STDs.

*Matters to be Discussed:* Agenda items include issues pertaining to: (1) HIV/STD/HCV Prevention, Treatment and Care in Federally Qualified Health Centers; (2) Biomedical Approaches to HIV Prevention—Pre-Exposure Prophylaxis; (3) Federal Adolescent Sexual Health Education Initiatives; and (4) Role of Surveillance in Informing CDC and HRSA Activities.

Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, CDC, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333, Telephone: (404) 639-8317.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry.

Dated: October 8, 2009.

Andre Tyler,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.